224,656 iRhythm Technologies $IRTC Shares Purchased by Voya Investment Management LLC

Voya Investment Management LLC raised its holdings in shares of iRhythm Technologies (NASDAQ:IRTC – Free Report) by 3,578.5% in the 3rd quarter, Holdings Channel.com reports. The fund owned 230,934 shares of the company’s stock after buying an additional 224,656 shares during the period. Voya Investment Management LLC’s holdings in iRhythm Technologies were worth $26,248,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Squarepoint Ops LLC lifted its stake in iRhythm Technologies by 1,065.8% during the second quarter. Squarepoint Ops LLC now owns 71,862 shares of the company’s stock worth $8,548,000 after purchasing an additional 65,698 shares during the last quarter. Hsbc Holdings PLC acquired a new position in iRhythm Technologies in the second quarter valued at approximately $528,000. Rock Springs Capital Management LP increased its stake in iRhythm Technologies by 11.4% in the first quarter. Rock Springs Capital Management LP now owns 261,750 shares of the company’s stock valued at $30,892,000 after purchasing an additional 26,750 shares during the last quarter. Quantinno Capital Management LP increased its stake in iRhythm Technologies by 1,172.8% in the first quarter. Quantinno Capital Management LP now owns 18,621 shares of the company’s stock valued at $2,198,000 after purchasing an additional 17,158 shares during the last quarter. Finally, First Light Asset Management LLC increased its stake in iRhythm Technologies by 9.3% in the first quarter. First Light Asset Management LLC now owns 168,116 shares of the company’s stock valued at $19,841,000 after purchasing an additional 14,245 shares during the last quarter.

Analyst Ratings Changes

IRTC has been the topic of a number of research analyst reports. Wall Street Zen downgraded shares of iRhythm Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, October 10th. Canaccord Genuity Group upped their target price on shares of iRhythm Technologies from $196.00 to $206.00 and gave the company a “buy” rating in a report on Friday, November 6th. Wells Fargo & Company dropped their target price on shares of iRhythm Technologies from $150.00 to $135.00 and set an “overweight” rating on the stock in a research report on Friday, November 6th. Citigroup lowered shares of iRhythm Technologies from a “buy” rating to a “neutral” rating and cut their price target for the stock from $157.00 to $124.00 in a research note on Friday, November 6th. Finally, Truist Financial cut their price target on shares of iRhythm Technologies from $168.00 to $140.00 and set a “buy” rating on the stock in a research note on Monday, November 9th. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, iRhythm Technologies currently has an average rating of “Moderate Buy” and an average price target of $164.07.

Get Our Latest Stock Analysis on iRhythm Technologies

iRhythm Technologies Trading Up 0.5%

NASDAQ:IRTC opened at $94.72 on Friday. The company has a market capitalization of $3.18 billion, a PE ratio of -80.96 and a beta of 1.39. iRhythm Technologies has a 52-week low of $82.85 and a 52-week high of $192.47. The stock’s 50 day moving average price is $109.28 and its 200 day moving average price is $118.36. The company has a quick ratio of 3.45, a current ratio of 3.57 and a debt-to-equity ratio of 3.68.

iRhythm Technologies (NASDAQ:IRTC – Get Free Report) last issued its quarterly earnings data on Thursday, November 5th. The company reported $0.82 earnings per share for the quarter, beating analysts’ consensus estimates of $0.02 by $0.80. iRhythm Technologies had a positive return on equity of 26.88% and a negative net margin of 4.52%. The company had revenue of $221.59 million during the quarter, compared to analysts’ expectations of $222.23 million. During the same quarter in the previous year, the business earned ($0.06) earnings per share. The firm’s revenue for the quarter was up 14.9% on a year-over-year basis. On average, research analysts anticipate that iRhythm Technologies will post 0.79 EPS for the current year.

iRhythm Technologies announced that its Board of Directors has authorized a share buyback program on Wednesday, November 11th that allows the company to repurchase $200 million in outstanding shares. This buyback authorization allows the company to reacquire up to 6.7% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s board of directors believes its stock is undervalued.

Insider Activity

In other iRhythm Technologies news, Director Abhijit Talwalkar bought 7,900 shares of the stock in a transaction dated Thursday, November 19th. The shares were acquired at an average cost of $96.67 per share, for a total transaction of $763,693.00. Following the completion of the transaction, the director owned 7,900 shares in the company, valued at approximately $763,693. The trade was a ? increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.98% of the company’s stock.

About iRhythm Technologies

(Free Report)

iRhythm Technologies is a medical technology company that develops digital solutions for detecting and monitoring heart rhythm disorders. Its services combine wearable electrocardiogram (ECG) devices with cloud-based data analysis and clinical reporting to help healthcare professionals assess patients for conditions such as cardiac arrhythmias. The company’s Zio product line includes wearable ECG monitors, such as Zio XT, which records a patient’s heart activity during an extended monitoring period. iRhythm also offers Zio AT, a monitoring service designed to provide clinicians with ECG data during the monitoring period.

Recommended Stories

Want to see what other hedge funds are holding IRTC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iRhythm Technologies (NASDAQ:IRTC – Free Report).

Institutional Ownership by Quarter for iRhythm Technologies (NASDAQ:IRTC)

Receive News & Ratings for iRhythm Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iRhythm Technologies and related companies with MarketBeat.com's FREE daily email newsletter.